SCHEMBL29940671

SCHEMBL29940671

Nc1c(Br)cc(C2CC2)cc1[N+](=O)[O-]

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.56
CYP3A4 P08684 3/20 0.56
CTSB P07858 1/20 0.46
MAPT P10636 9/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
LMNA P02545 1/20 0.36
MAPK1 P28482 2/20 0.35
TDP1 Q9NUW8 4/20 0.34
MEN1 O00255 4/20 0.34
KMT2A Q03164 4/20 0.34
POLB P06746 2/20 0.34
ALOX15 P16050 1/20 0.34
TSHR P16473 1/20 0.34
MCL1 Q07820 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
KDM4E B2RXH2 1/20 0.34
G6PD P11413 1/20 0.34
PKM P14618 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
RXFP1 Q9HBX9 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2319530 1.00 ALDH1A1 (0.56) ALDH1A1CYP3A4CTSBMAPTSMN1; SMN2
SCHEMBL29278033 0.94 ALDH1A1 (0.50) ALDH1A1CYP3A4CTSBMAPTSMN1; SMN2
SCHEMBL2321486 0.78 ALDH1A1 (0.46) ALDH1A1CYP3A4CTSBMAPTLMNA
SCHEMBL844679 0.74 MAPT (0.56) ALDH1A1CYP3A4MAPTLMNATDP1
SCHEMBL2319887 0.74 GAA (0.37) MAPT
SCHEMBL29706644 0.74 ALDH1A1 (0.68) ALDH1A1CYP3A4CTSBMAPTSMN1; SMN2
SCHEMBL2783704 0.74 ALDH1A1 (0.68) ALDH1A1CYP3A4CTSBMAPTSMN1; SMN2
SCHEMBL29277905 0.73 MAPT (0.47) ALDH1A1CYP3A4MAPTLMNAMAPK1
SCHEMBL18840406 0.72 ALDH1A1 (0.43) ALDH1A1CYP3A4CTSBMAPTSMN1; SMN2
SCHEMBL909587 0.72 ALDH1A1 (1.00) ALDH1A1CYP3A4CTSBMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025099451-A1 NEW COMPOUNDS AND METHODS Transition Bio Limited (GB) 2025-05-15 WO disclosed
EP-4308229-A1 INHIBITORS OF PLASMA KALLIKREIN Takeda Pharmaceutical Company Limited (JP) 2024-01-24 EP disclosed
WO-2022197763-A1 INHIBITORS OF PLASMA KALLIKREIN SHIRE HUMAN GENETIC THERAPIES, INC. (US) 2022-09-22 WO disclosed